Hematopoietic Cell Transplants Hardback with Online Resource

Hillard M. Lazarus is Professor of Medicine at the Case Comprehensive Cancer Center, Case Western Reserve University, University Hospitals Case Medical Center, Cleveland. Robert Peter Gale is a Visiting Professor at the Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London. Armand Keating is Professor of Medicine and Biomedical Engineering at the University of Toronto, and Director of the Cell Therapy Program, Princess Margaret Cancer Centre, Toronto. Andrea Bacigalupo is a Professor at the Cattedra Ematologia, Universita' Cattolica del Sacro Cuore, Fondazione Policlinico Unviersitario A Gemelli, Roma-Italia. Reinhold Munker is Professor of Medicine at Louisiana State University. Kerry Atkinson is Adjunct Professor at the University of Queensland Centre for Clinical Research; Adjunct Professor at the Stem Cell Laboratories, Queensland University of Technology at the Translational Research Institute; and Specialist in General Medicine at Salisbury Medical Centre, Brisbane. Syed Ali Abutalib is Assistant Director of the Hematology and Bone Marrow Transplant Program, Cancer Treatment Centers of America, Zion, Illinois.

Part I. Recipient Selection for Hematopoietic Cell Transplantation; Part II. Donor Selection for Allogeneic Hematopoietic Cell Transplants; Part III. Collecting and Processing of the Graft; Part IV. Early Posttransplant Interval; Part V. Infections after Hematopoietic Cell Transplantation – Progress?; Part VI. Late Complications of Hematopoietic Cell Transplantation; Part VII. Other Complications of Hematopoietic Cell Transplants; Part VIII. Prevention, Detection and Treatment of Relapse after Hematopoietic Cell Transplants; Part IX. Selection of Conditioning Regimen and Challenges with Different Types of T-Cell Depletion Methods; Part X. Hematopoietic Cell Transplants for Acute Leukemia and Myelodysplastic Syndrome; Part XI. Hematopoietic Cell Transplants for Myeloproliferative Neoplasms; Part XII. Hematopoietic Cell Transplants for Lymphomas – Changing Indications; Part XIII. Plasma Cell Dyscrasias; Part XIV. Autotransplants for Solid Neoplasms; Part XV. Hematopoietic Cell Transplants for Non-Neoplastic Diseases; Part XVI. Novel Transplant Strategies; Part XVII. Novel Cell Therapies and Manipulations.